AmerisourceBergen Specialty Group brings specialty pharmaceuticals from the manufacturer... to the physician... to the patient.

We help manufacturers improve their product launches and expand their markets. We ensure that provider organizations receive the specialty products they need, when they need them most. We give physicians the resources that improve their practices and patients the medicines that improve their lives.

Rely on our knowledgedriven services.

Our Services

pharma & specialty services

distribution & physician services

NEWS

MAY 2009 AmerisourceBergen Specialty Group releases new proprietary reports on three, crucial industry topics: Perspectives on Biosimilars, Comparative Effectiveness: Rational vs. Rationing and The Changing Cost of Cancer. Click here to learn more.

DECEMBER 2008 AmerisourceBergen Specialty Group featured in a Pharmaceutical Commerce article on new REMS regulations

NOVEMBER 2008 Xcenda provides analysis on President-elect Obama's potential impact on the war on cancer in Oncology Business Review

 

EDUCATION

Register for our June 25 webcast, "The Unvarnished Truth about Comparative Effectiveness." Learn the Specialty Group's perspective on what comparative effectiveness will encompass, how it will impact access to medications and what manufacturers can do to prepare.

View our on-demand webcast, "Change is Coming to Healthcare, But When?" Hear analysis of health policy changes to-date, likely initiatives for President Obama and the Democratic-controlled Congress, as well as the impact these initiatives may have on manufacturers, payers, physicians and patients.

 

RESOURCES

Download our latest podcast, "REMS: Is it the end of the world as we know it?"  Listen as we examine key operational and clinical considerations of successful REMS programs—what makes a program work and what impact it can have. (Presented in conjunction with Pharmaceutical Executive magazine.)

Sign up now to receive Partnered for Growth, your free guide to the life cycle issues impacting your business and how you can address them.